Here, we proposed a novel mechanism by which LicA could inhibit ovarian cancer cell malignancy by downregulating STAT3 translation initiation in SKOV3 cells and then lowering STAT3 protein and activation levels. This evidence concerns the gene STAT3 and ovarian cancer.